|Advisory sell side||Results International | M&A Advisory
BDO | Financial and Tax Advisory
Osborne Clarke | Legal Advisory
NautaDutilh | Legal Advisory
Smith Anderson | Legal Advisory
Addisons | Legal Advisory
|Advisory buy side||Rothschild & Co | M&A Advisory
BDO | M&A Advisory
Dentons | Legal Advisory
KPMG | Financial and Tax Advisory
Roland Berger | Commercial Advisory
|Data Room provider||Virtual Vaults
Leading European private equity firm Astorg has acquired a majority stake in Avania Clinical from Kester Capital. Avania is one of the world's leading clinical CROs ("Contract Research Organizations") dedicated to medical technology.
Avania is one of the world's leading providers of outsourced clinical trial services, focusing on medical technology and covering the entire regulatory lifecycle across a broad range of therapeutic areas.
Kester Capital is the leading acquisition specialist. Kester focuses on healthcare, data and information and technology, targeting companies that need capital to realize their potential. Along with Kester, who intends to retain a minority stake, Astorg brings an impressive global network of medtech relationships that will strengthen Avania's pipeline development and expand its customer base, while access to funding will help support its growth to organically land and through acquisitions.